A groundbreaking study led by researchers from The University of Texas at Austin and Harvard Medical School has challenged the prevailing assumption that infants exposed to gestational diabetes mellitus (GDM) are at an automatically higher risk of developing childhood obesity. Published in the
In a significant move towards revolutionizing pediatric care, Little Journey, a digital health startup, has secured £6 million in Series A funding. This development aims to enhance its personalized psychological support platform for children and families interacting with healthcare systems. As a
Stéphanie Gauvin and Tim MacIsaac, a devoted couple hailing from Nova Scotia, have embarked on a challenging and emotional journey to save their five-year-old golden doodle, Lucy, diagnosed with T-cell lymphoma. In their quest to find the best possible treatment for Lucy, they have encountered
The groundbreaking study conducted by researchers from the Champalimaud Foundation sheds new light on the complex and previously misunderstood relationship between dopamine levels in the brain and rest tremor in patients with Parkinson's Disease (PD). Published in npj Parkinson's Disease,
In the evolving landscape of transgender healthcare, a profound area of research delves into how hormone therapy and puberty blockers affect skeletal dimensions in transgender individuals. Presented at the 62nd Annual European Society for Paediatric Endocrinology Meeting in Liverpool,
Growth hormone-releasing hormone (GHRH), also known as somatoliberin, has emerged as a significant focus in medical research due to its extensive biological activities and therapeutic potential. GHRH, a family of hypothalamic peptide hormones, plays a crucial role in stimulating and modulating the
The promising results of a new clinical trial investigating the efficacy of inebilizumab in treating immunoglobulin G4-related disease (IgG4-RD), a rare immune system affliction, have ignited hope for a groundbreaking treatment. The clinical trial, led by researchers from Mass General Brigham, has
The recent study from City St George's, University of London, published in Ultrasound in Obstetrics and Gynecology, highlights a significant increase in congenital heart defects among newborns during the Covid-19 pandemic. With over 18 million birth records examined, researchers found that the
Benitec Biopharma Inc., headquartered in Hayward, California, has recently released its financial results for the first quarter of fiscal 2025. Alongside this, the company has provided an extensive operational update, highlighting significant clinical progress, financial health, and a detailed
In a significant move for the oncology field, ARTBIO, Inc. has entered into a groundbreaking partnership with 3B Pharmaceuticals GmbH that aims to advance a novel alpha radioligand therapy for treating solid tumors. ARTBIO, known for its innovative AlphaDirect™ platform, focuses on 212Pb-based a
